心脏移植后血管麻痹综合征的预测因素与严重程度特征分析
该回顾性研究纳入3年内连续244例心脏移植患者,按术后血管麻痹程度分为无、轻度(需1种血管升压药)和中/重度(需2种以上血管升压药)三组,分析风险因素及预后。血管麻痹综合征发生率为34.3%(轻度74.1%,中/重度25.9%)。中/重度组体外循环时间和术前肌酐显著更高,机械循环支持使用呈较强趋势;三组1年生存率、无排斥反应率和透析需求无显著差异。血管麻痹与插管时间延长、血制品使用增多和住院时间延长相关,作者认为需更大样本进一步研究。
要点
- 心脏移植后血管麻痹综合征发生率为34.3%,其中轻度占74.1%,中/重度占25.9%。
- 中/重度血管麻痹组体外循环时间显著更长、术前肌酐显著更高。
- 三组1年生存率、无排斥反应率和透析需求无显著差异。
核心结论
- 血管麻痹综合征在心脏移植后常见,严重程度增加的风险因素包括体外循环时间更长和术前肌酐升高。
- 虽未检测到死亡率或移植物排斥率更高,但血管麻痹与插管时间延长、血制品使用增多和住院时间延长相关。
- 作者认为需要更大样本的进一步研究。
研究设计与样本
- 回顾性综述,纳入3年期间连续244例接受心脏移植的患者。
- 患者分为三组:无血管麻痹、轻度血管麻痹(需1种血管升压药)、中/重度血管麻痹(需2种以上血管升压药)。
- 评估1年生存率、无排斥反应率和术后并发症发生率,并回顾性识别血管麻痹亚组的风险因素。
主要发现
- 心脏移植后血管麻痹综合征发生率为34.3%,其中轻度占74.1%,中/重度占25.9%。
- 中/重度血管麻痹组体外循环时间显著更长,术前肌酐显著更高。
- 中/重度血管麻痹患者相比轻度和无血管麻痹患者,机械循环支持使用呈较强趋势。
- 心脏移植后1年生存率、无排斥反应率和血液透析需求在各组间无显著差异。
- 血管麻痹与插管时间延长、血制品使用增多和住院时间延长相关。
关键数值与推荐
- 血管麻痹分组标准:轻度为需1种血管升压药,中/重度为需2种以上血管升压药。
- 血管麻痹综合征发生率为34.3%;轻度占74.1%,中/重度占25.9%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
- 作者在结论中提出需要更大样本的进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vasoplegia is characterized as a severe vasodilatory shock after cardiac surgery, and can be associated with substantial morbidity. Increased systemic inflammation and endothelial dysfunction, often related to prolonged cardiopulmonary bypass times, anesthesia, or mechanical circulatory support have been shown to be associated with the development of vasoplegia. We sought to identify risk factors and the impact of various degrees of vasoplegia after heart transplantation. METHODS: A retrospective review was conducted of 244 consecutive patients who underwent heart transplantation over a 3-year period. Patients were divided into three groups: no vasoplegia, mild vasoplegia (requiring one vasopressor), and moderate/severe vasoplegia (more than two vasopressors). One-year survival, freedom from rejection, and postoperative complication rates were assessed. Risk factors for vasoplegia subgroups were retrospectively identified. RESULTS: Vasoplegia syndrome was observed in 34.3% of patients after heart transplantation (mild, 74.1%; moderate/severe, 25.9%). Cardiopulmonary bypass time was significantly longer and pretransplant creatinine was significantly higher in the moderate/severe vasoplegia group. There was a strong trend toward greater use of mechanical circulatory support among moderate/severe vasoplegia patients compared with mild and no vasoplegia patients. After heart transplantation, 1-year survival, freedom from rejection, and need for hemodialysis were not significantly different between groups. CONCLUSIONS: Vasoplegia syndrome is common after heart transplantation. Risk factors for increased severity include longer cardiopulmonary bypass times and elevated preoperative creatinine. Although higher rates of mortality or graft rejection were not detected, vasoplegia was associated with prolonged intubation, greater blood product usage, and lengthened hospital stay. Further studies involving larger cohorts are warranted.
引用
- Chan JL, Kobashigawa JA, Aintablian TL, et al. Characterizing Predictors and Severity of Vasoplegia Syndrome After Heart Transplantation. Ann Thorac Surg. 2017. PMID: 29289367. doi:10.1016/j.athoracsur.2017.09.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。